Users Online: 150

Home Print this page Email this page Small font sizeDefault font sizeIncrease font size

Home | About us | Editorial board | Search | Ahead of print | Current issue | Archives | Submit article | Instructions | Subscribe | Contacts | Login 
     

   Table of Contents      
EDITORIAL
Year : 2018  |  Volume : 8  |  Issue : 3  |  Page : 67-69

Good prescribing to maximize patient benefit


Faculty of Medicine and Defence Health, Universiti Pertahanan Nasional Malaysia (National Defence University of Malaysia), Kem Perdana Sungai Besi, 57000 Kuala Lumpur, Malaysia

Date of Web Publication20-Jun-2018

Correspondence Address:
Mainul Haque
Faculty of Medicine and Defence Health, Universiti Pertahanan Nasional Malaysia (National Defence University of Malaysia), Kem Perdana Sungai Besi, 57000 Kuala Lumpur
Malaysia
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/ijnpnd.ijnpnd_31_18

Rights and Permissions

How to cite this article:
Haque M. Good prescribing to maximize patient benefit. Int J Nutr Pharmacol Neurol Dis 2018;8:67-9

How to cite this URL:
Haque M. Good prescribing to maximize patient benefit. Int J Nutr Pharmacol Neurol Dis [serial online] 2018 [cited 2018 Sep 23];8:67-9. Available from: http://www.ijnpnd.com/text.asp?2018/8/3/67/234816


   Contextual Issues Top


The prescribing of medicines is the most common and complex intervention process of healthcare. It is the very first step of the medicine utilization process.[1],[2] The use of effective, safe medications has an essential part of modern healthcare system.[1] The Royal Pharmaceutical Society of Great Britain recognized that prescribing is “a technically difficult, and morally complex, problem[3] and honestly it is doubtful objective whether will patient adheres to the prescribed medicine.[3],[4],[5],[6],[7] The writing of flawless, explicit prescriptions by a medical doctor is considered as an art erudite though prolong years of practice and indoctrination.[8] Thereafter, prudent use of medicine ensures the success of the pharmacologic intervention.[9] The prescribing practices of a medical doctor are controlled by multiple issues which include the physician his/herself, the practice backdrop, and the health-care system.[10],[11],[12],[13],[14]


   Good Prescribing Top


The quality prescribing medicine is an imperative element to ensure and improve patient care in any community, and balancing demands for increased effective prescribing with the risk of adverse drug reactions (ADRs) is a demanding issue for any healthcare system.[15] Many prescribing quality indicators based on register data have been proposed, and several are used regularly. Prescription data are often used for indicators; however, they do not make available any straightforward evidence about disease and patient aspects significant for assessing the excellence of prescribing.[16] Multiple governmental bodies and concern group increasingly giving more attention regarding the irrational use of medicine. Nevertheless, standards defining the prudent or instinctual use of medicine are not readily accessible and are not systematic and reliable.[17] Plummeting imprudent use of medicine is well-thought-out as the best and most cost-effective approach to improve the quality of healthcare and limit waste of limited resources.[17] Rational prescribing necessitates the medical doctor to make a precise diagnosis, comprehend the pathophysiology of the disease, knowledge of pharmacology regarding medicine to be prescribed, and need to consider multiple aspects of the patients and medicine.[18],[19] A good prescription must consequently contemplate (1) pertinent patient aspects and “comorbidities, (2) evidence-based knowledge on medically sound prescribing practices, and (3) the setting in which a prescription is issued.”[20] The King's Fund in commissioned for improving quality care described good prescribing as “the NHS might define it as the lowest-cost prescribing that meets public health needs. The Department of Health and commissioners are keen to monitor prescribing and may measure good prescribing according to the available information and as this largely relates to drug costs, their definitions of good prescribing tend to use cost as the focus. The pharmaceutical industry may look on good prescribing as prescribing the latest drug to all patients who have need of treatment on the basis that new equals better. Evidence-based practitioners tend to define it as the use of therapies proven to be most effective in randomized controlled trials, or according to evidence-based guidelines.[21] Dr. Jeffrey Kenneth Aronson, a British clinical pharmacologist describes that a good prescribing is one that “recommends a medicine appropriate to the patient's condition and minimizes the risk of undue harm from it.” Aronson's definition was in covenant with Nick Barber, Professor of the Practice of Pharmacy who clarified that a good prescribing is one that accomplishes the four objectives, explicitly: (1) to maximize effectiveness; (2) minimize risks; (3) minimize costs; and (4) respect the patient's choices.[22],[23] Dr. Barber additionally specifies that this conceptualization of good prescribing “brings together the traditional balancing of risks and benefits with the need to reduce costs and the right of the patient to make choices in treatment.”[23]


   Hazards of Irrational Prescribing Top


Even though medicine cure or alleviate, irrational prescribing increases adverse drug reaction and healthcare cost. These obnoxious aspects of utilization of medicine have been testified to be substantial causes of morbidity, mortality, institutionalization, and individual cost of treatment.[24] Multiple research studies estimated that on average, $76.6–85 billion was spent annually in the United States to resolve drug-related problems.[25],[26] The amount was much higher than the findings of the Institute of Medicine.[27] Another study reported that the cost implications of ADRs could also be enormous.[28] In Germany, for illustration,[29] ADRs are assessed to cost more than €430 million per annum, however, in the UK, the cost of emergency admissions succeeding to an ADRs had valued at £2 billion per year.[30] An American molecular biologist and Nobel Laureate Joshua Lederberg describe regarding irrational antimicrobial use that in “the future of humanity and microbes will evolve as episodes of a suspense thriller that could be titled of our wits versus their genes.”[31] Dr. Lederberg further mentioned that irresponsible human practice such as the indiscriminate use of antimicrobials is one of the substantial aspects underlying the global uprising of antimicrobial resistance.[31] Irrational prescribing of painkillers and tranquilizers can lead to developing drug dependence; the overuse of injections can increase possibility abscesses, hepatitis B, and HIV/AIDS and increased the workload for health professionals.[32],[33]


   Strategies to Ensure Good Prescribing Top


Irrational use of medicines is a most important health challenge for our planet with noteworthy consequences for patients, healthcare systems, and communities.[34] The WHO considers irrational prescribing is a disease which is tough to cure – though deterrence possible.[35] The educational and managerial intervention was widely considered as a principal-targeted approach to ensure good prescribing.[36],[37],[38] Educational interventions will improve doctors' knowledge and awareness, but their efficiency in changing deeds remains modest unless used in combination with regulatory and economic interventions.[38],[39] It will be much better if educational intervention started as early as possible especially during undergraduate medical studies to develop good prescribing skill.[40] As when medical students will be graduated, they obtain license and freedom to prescribe of their own and many occasions prescribing without supervision. Again, once the bad habit of irrational prescribing develops it will be very difficult to cure.[41]


   Conclusion Top


The WHO-6-step method for pharmacotherapy education needs to be executed in each-every medical school curriculum “as part of an integrated learning program which has positive effects on medical students' knowledge of basic and applied pharmacology, pharmacotherapy skills, and satisfaction and confidence in prescribing.”[42] Furthermore, those medical doctors already graduated, and practicing should constantly update the new biomedical knowledge regarding medicine and clinical pharmacology to strengthen their prescribing skill.[43] Moreover, medical doctors must utilize every opportunity to counsel their patient for healthy living, balanced diet, and physical activity. In addition, in improving the prudent use of medicine and maximize patients' benefit, there is an urgent need for collaboration among all stakeholders of healthcare especially doctors, nurses, and pharmacist.[44] Online national database, regarding patient information, medical records, drug interaction, and repeat prescriptions, etc., can minimize preventable harm from the medication-related issue.[45],[46]

 
   References Top

1.
Kar SS, Pradhan HS, Mohanta GP. Concept of essential medicines and rational use in public health. Indian J Community Med 2010;35:10-3.  Back to cited text no. 1
[PUBMED]  [Full text]  
2.
Suthar JV, Patel VJ, Vaishnav B. Quality of prescribing for hypertension and bronchial asthma at a tertiary health care facility, India using prescription quality index tool. J Basic Clin Pharm 2014;6:1-6.  Back to cited text no. 2
    
3.
Royal Pharmaceutical Society of Great Britain. From Compliance to Concordance: Achieving Shared Goals in Medicine Taking. London: RPS; 1997.  Back to cited text no. 3
    
4.
Jimmy B, Jose J. Patient medication adherence: Measures in daily practice. Oman Med J 2011;26:155-9.  Back to cited text no. 4
    
5.
Jin J, Sklar GE, Min Sen Oh V, Chuen Li S. Factors affecting therapeutic compliance: A review from the patient's perspective. Ther Clin Risk Manag 2008;4:269-86.  Back to cited text no. 5
    
6.
Brown MT, Bussell JK. Medication adherence: WHO cares? Mayo Clin Proc 2011;86:304-14.  Back to cited text no. 6
    
7.
Atreja A, Bellam N, Levy SR. Strategies to enhance patient adherence: Making it simple. MedGenMed 2005;7:4.  Back to cited text no. 7
    
8.
Neyaz Y, Khoja T, Qureshi NA, Magzoub MA, Haycox A, Walley T, et al. Predictors of quality of medication prescribing in primary care in Riyadh city, Saudi Arabia. East Mediterr Health J 2011;17:167-71.  Back to cited text no. 8
    
9.
Lee CR, Cho IH, Jeong BC, Lee SH. Strategies to minimize antibiotic resistance. Int J Environ Res Public Health 2013;10:4274-305.  Back to cited text no. 9
    
10.
Mosadeghrad AM. Factors influencing healthcare service quality. Int J Health Policy Manag 2014;3:77-89.  Back to cited text no. 10
    
11.
Helin-Salmivaara A, Huupponen R, Klaukka T, Hoppu K; Steering Group of the ROHTO Programme. Focusing on changing clinical practice to enhance rational prescribing – Collaboration and networking enable comprehensive approaches. Health Policy 2003;66:1-10.  Back to cited text no. 11
    
12.
Effken JA, Brewer BB, Patil A, Lamb GS, Verran JA, Carley K, et al. Using OrgAhead, a computational modeling program, to improve patient care unit safety and quality outcomes. Int J Med Inform 2005;74:605-13.  Back to cited text no. 12
    
13.
Dineen KK, DuBois JM. Between a rock and a hard place: Can physicians prescribe opioids to treat pain adequately while avoiding legal sanction? Am J Law Med 2016;42:7-52.  Back to cited text no. 13
    
14.
Mosadeghrad AM. Factors affecting medical service quality. Iran J Public Health 2014;43:210-20.  Back to cited text no. 14
    
15.
Rochon PA, Gurwitz JH. Prescribing for seniors: Neither too much nor too little. JAMA 1999;282:113-5.  Back to cited text no. 15
    
16.
Andersen M. Is it possible to measure prescribing quality using only prescription data? Basic Clin Pharmacol Toxicol 2006;98:314-9.  Back to cited text no. 16
    
17.
Beers MH, Ouslander JG, Rollingher I, Reuben DB, Brooks J, Beck JC, et al. Explicit criteria for determining inappropriate medication use in nursing home residents. UCLA division of geriatric medicine. Arch Intern Med 1991;151:1825-32.  Back to cited text no. 17
    
18.
Maxwell S. Rational prescribing: The principles of drug selection. Clin Med (Lond) 2009;9:481-5.  Back to cited text no. 18
    
19.
Akici A, Kalaça S, Gören MZ, Akkan AG, Karaalp A, Demir D, et al. Comparison of rational pharmacotherapy decision-making competence of general practitioners with intern doctors. Eur J Clin Pharmacol 2004;60:75-82.  Back to cited text no. 19
    
20.
Seidling HM, Haefeli WE. Good Prescribing Practice. Ther Umsch 2014;71:313-6.  Back to cited text no. 20
    
21.
The King's Fund. Improving the Quality of Care in General Practice: Report of an Independent Inquiry Commissioned by The King's Fund. London, UK: King's Fund; 2011.  Back to cited text no. 21
    
22.
Aronson JK. Balanced prescribing. Br J Clin Pharmacol 2006;62:629-32.  Back to cited text no. 22
    
23.
Barber N. What constitutes good prescribing? BMJ 1995;310:923-5.  Back to cited text no. 23
    
24.
Andrews J. Death and the dead-house in victorian asylums: Necroscopy versus mourning at the Royal Edinburgh Asylum, C 1832-1901. Hist Psychiatry 2012;23:6-26.  Back to cited text no. 24
    
25.
Bootman JL, Harrison DL, Cox E. The health care cost of drug-related morbidity and mortality in nursing facilities. Arch Intern Med 1997;157:2089-96.  Back to cited text no. 25
    
26.
Johnson JA, Bootman JL. Drug-related morbidity and mortality. A cost-of-illness model. Arch Intern Med 1995;155:1949-56.  Back to cited text no. 26
    
27.
Fick DM, Cooper JW, Wade WE, Waller JL, Maclean JR, Beers MH, et al. Updating the beers criteria for potentially inappropriate medication use in older adults: Results of a US consensus panel of experts. Arch Intern Med 2003;163:2716-24.  Back to cited text no. 27
    
28.
Godman B, Finlayson AE, Cheema PK, Zebedin-Brandl E, Gutiérrez-Ibarluzea I, Jones J, et al. Personalizing health care: Feasibility and future implications. BMC Med 2013;11:179.  Back to cited text no. 28
    
29.
Rottenkolber D, Schmiedl S, Rottenkolber M, Farker K, Saljé K, Mueller S, et al. Adverse drug reactions in Germany: Direct costs of internal medicine hospitalizations. Pharmacoepidemiol Drug Saf 2011;20:626-34.  Back to cited text no. 29
    
30.
Pirmohamed M, James S, Meakin S, Green C, Scott AK, Walley TJ, et al. Adverse drug reactions as cause of admission to hospital: Prospective analysis of 18 820 patients. BMJ 2004;329:15-9.  Back to cited text no. 30
    
31.
Lederberg J. Infectious history. Science 2000;288:287-93.  Back to cited text no. 31
    
32.
Ofori-Asenso R, Brhlikova P, Pollock AM. Prescribing indicators at primary health care centers within the WHO African region: A systematic analysis (1995-2015). BMC Public Health 2016;16:724.  Back to cited text no. 32
    
33.
Aina BA, Tayo F, Taylor O. Cost implication of irrational prescribing of chloroquine in Lagos state general hospitals. J Infect Dev Ctries 2008;2:68-72.  Back to cited text no. 33
    
34.
Ofori-Asenso R, Agyeman AA. Irrational use of medicines – A summary of key concepts. Pharmacy (Basel) 2016;4. pii: E35.  Back to cited text no. 34
    
35.
World Health Organization. Teacher's Guide to Good Prescribing. Department of Essential Drugs and Medicines Policy. Geneva, Switzerland: World Health Organization; 2001. Available from: http://www.apps.who.int/medicinedocs/documents/s15940e/s15940e.pdf. [Last accessed on 2017 Sep 23].  Back to cited text no. 35
    
36.
Herbert CP, Wright JM, Maclure M, Wakefield J, Dormuth C, Brett-MacLean P, et al. Better prescribing project: A randomized controlled trial of the impact of case-based educational modules and personal prescribing feedback on prescribing for hypertension in primary care. Fam Pract 2004;21:575-81.  Back to cited text no. 36
    
37.
Hogerzeil HV. Promoting rational prescribing: An international perspective. Br J Clin Pharmacol 1995;39:1-6.  Back to cited text no. 37
    
38.
Management Sciences for Health. MDS-3-Managing Access to Medicines and Health Technologies. Arlington, VA, USA: Management Sciences for Health (MSH); 2012.  Back to cited text no. 38
    
39.
Wettermark B, Godman B, Jacobsson B, Haaijer-Ruskamp FM. Soft regulations in pharmaceutical policy making: An overview of current approaches and their consequences. Appl Health Econ Health Policy 2009;7:137-47.  Back to cited text no. 39
    
40.
Wilcock J, Strivens J. A study to enhance medical students' professional decision-making, using teaching interventions on common medications. Med Educ Online 2015;20:27097.  Back to cited text no. 40
    
41.
de Vries TP, Henning RH, Hogerzeil HV, Fresle DA. Guide to Good Prescribing: A Practical Manual. Action Programme on Essential Drugs. Geneva: World Health Organization; 1994. Available from: http://www.apps.who.int/medicinedocs/pdf/whozip23e/whozip23e.pdf. [Last accessed on 2017 Sep 23].  Back to cited text no. 41
    
42.
Keijsers CJ, Segers WS, de Wildt DJ, Brouwers JR, Keijsers L, Jansen PA, et al. Implementation of the WHO-6-step method in the medical curriculum to improve pharmacology knowledge and pharmacotherapy skills. Br J Clin Pharmacol 2015;79:896-906.  Back to cited text no. 42
    
43.
Birkett D, Brøsen K, Cascorbi I, Gustafsson LL, Maxwell S, Rago L, et al. Clinical pharmacology in research, teaching and health care: Considerations by IUPHAR, the international union of basic and clinical pharmacology. Basic Clin Pharmacol Toxicol 2010;107:531-59.  Back to cited text no. 43
    
44.
Smith WE. Role of a pharmacist in improving rational drug therapy as part of the patient care team. Ann Pharmacother 2007;41:330-5.  Back to cited text no. 44
    
45.
Price J, Man SL, Bartlett S, Taylor K, Dinwoodie M, Bowie P, et al. Repeat prescribing of medications: A system-centred risk management model for primary care organisations. J Eval Clin Pract 2017;23:779-96.  Back to cited text no. 45
    
46.
Stocks SJ, Kontopantelis E, Akbarov A, Rodgers S, Avery AJ, Ashcroft DM, et al. Examining variations in prescribing safety in UK general practice: Cross sectional study using the Clinical Practice Research Datalink. BMJ 2015;351:h5501.  Back to cited text no. 46
    




 

Top
 
 
  Search
 
    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
    Access Statistics
    Email Alert *
    Add to My List *
* Registration required (free)  

 
  In this article
   Contextual Issues
   Good Prescribing
    Hazards of Irrat...
    Strategies to En...
   Conclusion
    References

 Article Access Statistics
    Viewed601    
    Printed51    
    Emailed0    
    PDF Downloaded45    
    Comments [Add]    

Recommend this journal